1 Day ALT 3.86% DJIA -0.31% Russell 2K -0.63% Health Care/Life Sciences -0.46% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...
Nov. 15, 2024 (G Altimmune ( NASDAQ:ALT ) Third Quarter 2024 Results Key Financial Results Net loss: US$22.8m (loss widened by 11% from... GAITHERSBURG, Md., Nov. 11, 2024 (GLOBE NEWSWIRE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback